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Yan-Hong Li1,2,3* and Wei Zhang1,3*Abstract: Malignant melanoma involving the respiratory tract is nearly always metastatic in origin, and primary
tumors are very rare. To our knowledge, about 30 cases have been reported in the English literature, one of which
involved multiple brain metastases. Here, we report two cases of primary pulmonary malignant melanoma. The first
case, which occurred in a 52-year-old Chinese female patient who died 4 months after the initial diagnosis,
involved rapid intrapulmonary and intracranial metastases. The second patient, a 65-year-old female, underwent
surgical excision, and clinical examination, histopathological characteristics, and immunohistochemical features
supported the diagnosis of pulmonary malignant melanoma. No evidence for recurrence and/or metastasis has
been found more than one year after the initial surgery. To establish the diagnosis of primary pulmonary malignant
melanoma, any extrapulmonary origin must be excluded by detailed examination. Moreover, the tumor should be
removed surgically whether it occurs as a single lesion or multiple lesions.
Virtual slide: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/
1480477335765055.
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Malignant melanoma occurs most frequently on the skin,
but can also arise in other organs and tissues of the body.
However, primary pulmonary malignant melanoma is
exceedingly rare [1]. To date, about 30 cases have been
reported in the English literature [2], one of which involved
multiple brain metastases [3]. This report presents two
cases of primary malignant melanoma of the lung, and one
case involves intrapulmonary and intracranial metastasis.
The goal of this study was to illustrate the importance of
establishing the diagnosis of primary pulmonary malignant
melanoma by detailed examination upon diagnosis to
exclude any extrapulmonary origin. Moreover, the tumor
should be removed surgically whether it occurs as a single
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Case 1
A 52-year-old Chinese female was admitted to our hos-
pital because of a persistent cough. Previous computed
tomography (CT) of the chest revealed multiple ill-
defined masses in the upper and lower lobe of the left
lung. Clinical examinations and routine laboratory tests
were within normal limits. Comprehensive dermatologic
and ophthalmologic examinations revealed no evidence
of cutaneous or ocular primary melanoma. Broncho-
scopic examination showed a bulging lesion in the bron-
chus of the lower left lobe, and a bronchial mucosal
biopsy was performed. Histopathologically, the tumor
cells were submucosal, and were composed of malignant
epithelioid cells with large amounts of acidophilic cyto-
plasm and prominent nuclei. Mitotic figures were easily
found. Dark brown pigment was observed in some
tumor cells (Figure 1). Thus, our initial diagnosis was
malignant melanoma. Immunohistochemical staining to
confirm this diagnosis demonstrated that the tumor cells
were positive for pan melanoma, S-100 protein, Vimentin,
and HMB45 (melanoma marker) (Figure 2), and were
negative for cytokeratin (CK), epithelial membranetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Histopathological characteristics of pulmonary malignant melanoma: The tumor cells located under bronchial mucosa, and
was composed of malignant epithelioid tumor cells with large amounts of acidophilic cytoplasm and prominent nuclei. Mitotic figures
were easily found. Dark brown pigment were observed in some tumor cells (A, ×200; B, C, and D, ×400).
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(Syn), high molecular weight cytokeratin, small cell
lung cancer (SCLC) , Desmin, smooth muscle actin
(SM-actin), neuron specific enolase (NSE), leukocyte
common antigen (LCA), and CD34. Based upon these
histological characteristics, immunohistochemical fea-
tures, and the fact that there was no evidence ofFigure 2 Immunohistochemical features of pulmonary malignant mel
demonstrated the tumor cells were positive for pan- Melanoma (Figu
(Figure 2C, ×200), and Vimentin (Figure 2D, ×200).malignant melanoma elsewhere, the final diagnosis was pri-
mary pulmonary malignant melanoma. The patient under-
went regular adjuvant chemotherapy with dacarbazine.
Three months after the initial diagnosis, the patient felt
intermittent dizziness, and a cranial CT showed a solitary
lesion in the occipital lobe. The physician thought that the
intracranial lesion might be a metastatic focus, and advisedanoma: The results of immunohistochemical staining
re 2A, ×200), HMB45 (Figure 2B, ×200), S-100 protein
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undergo treatment and left hospital. At the end, she died 4
months after the initial diagnosis.
Case 2
A 65-year-old Chinese female was admitted to our hos-
pital due to shortness of breath and weakness of 8
months’ duration. She was initially treated with antibio-
tics for 1 week at home. However, her condition did not
improve, and she was admitted to our hospital for fur-
ther studies. A chest CT revealed a spherical mass in the
lower lobe of the right lung. Her cranial CT was normal
(Figure 3). Clinical examinations and routine laboratory
tests were within normal limits. The patient demanded
and received surgical treatment. Grossly, the mass mea-
sured 6×4×4 cm, the cut surface was dark, and the tex-
ture was solid. Histological examination revealed the
features of malignant melanoma with predominantly
epitheliod cells and nuclei (Figure 4). This was further
confirmed by immunohistochemistry, which showed
that the tumor cells expressed pan melanoma, HMB45,
and S-100 protein (Figure 4). As the same as the first
patient, various examinations demonstrated that there
was no lymph node metastasis or evidence of melanoma
elsewhere. The final diagnosis was primary pulmonary
malignant melanoma. Thus, the patient began adju-
vant chemotherapy with dacarbazine three weeks after
operation. To date, she is alive one year and six months
after initial diagnosis. Moreover, there is no evidence of
recurrence and/or metastasis.
Discussion
Worldwide, approximately 160,000 new cases of melanoma
are diagnosed each year, and about 41,000 melanoma-
related deaths occur annually [4]. Malignant melanoma
mainly occurs on the skin, but has also been described in
other mucosal sites and organs, including the oral cavity,
paranasal sinuses, esophagus, larynx, vagina, anorectal re-
gion, and liver [5,6]. Primary malignant melanoma of the
lung is an extremely rare non-epithelial neoplasm thatFigure 3 Chest and cranial CT of the second patient: A chest Comput
lower lobe (Figure 3A), and cranial CT showed normal (Figure 3B).accounts for only 0.01% of all primary lung tumors [7]. To
date, about 30 cases have been reported in the English lit-
erature [2]. The mean age at diagnosis is 57 years (range
41–82). Although it appears to be dominant in males, both
cases described in this report were female.
The precise histogenesis of pulmonary malignant melanoma
remains controversial. Most experts believe that melano-
cytes migrate concomitantly with reduced growth of the
primordial tubular respiratory tract during fetal growth [8].
Others think that these cases are a metastatic form of an
antecedent skin lesion that is either unrecognized or has
spontaneously regressed [9]. In addition, there are some
likely explanations regarding the presence of melanoma in
the lung, such as the possibility that melanocytes and mela-
nocytic proliferations are present in the larynx and esopha-
gus, or that the larynx, esophagus, and lungs all share a
common embryologic origin, suggesting the possible mi-
gration of melanocytes [10].
Pathologically, primary pulmonary malignant melanoma
resembles that of the skin or mucosa, and exhibits mor-
phologic variability within the tumor sample. Microscopic-
ally, the tumor is composed of epithelioid cells arranged
in nests, or spindle cells arranged in fascicles, with or
without melanin pigment deposition. Mitotic figures are
readily apparent. In both of our cases, the tumor cells
were mainly submucosal and showed diffuse infiltration.
They were pleomorphic, with round, spindle-shapes, ir-
regular morphologies, and prominent nuclei. Some tumor
cells contained melanin deposits. Thus, in similar cases,
malignant melanoma should be the first consideration.
However, immunohistochemical staining should also be
performed to further confirm this diagnosis, and to exclude
other melanotic tumors, such as melanotic medullary car-
cinoma of thyroid [11], and pigmented neuroendocrine car-
cinoma [12]. In our two cases, immunohistochemical
staining demonstrated that the tumor cells expressed
HMB45, S-100, pan melanoma and Vimentin, and did
not express CK, EMA, CgA, Syn, HCG, HMW-CK,
Desmin, SM-actin, TTF-1, and SCLC. Thus, the diag-
nosis was reliable, although there was no evidence ofed tomography (CT) revealed a spherical mass in the right lung
Figure 4 Histopathological characteristics and immunohistochemical features of the second case of pulmonary malignant melanoma:
Histopathologically, the tumor was composed of malignant epitheliod tumor cells with large amounts of acidophilic cytoplasm and
prominent nuclei. Mitotic figures were easily found. Lung tissue could be found in the surrounding of tumor cells (Figure 4A ×200and 4B ×400).
Immunohistochemically, the tumor cells were positive for vimentin (Figure 4C ×200), S-100 protein (Figure 4D ×200), melanoma-pan (Figure 4E
×200), and HMB45 (Figure 4F ×200).
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examination.
According to the published literature, approximately
5-10% of patients with metastatic melanoma have a pri-
mary melanoma of unknown origin [13,14]. Various rea-
sons, such as occult cutaneous or visceral location,
complete regression, or primary origin in lymph nodes
due to malignant transformation of ectopic nevus cells,
have been suggested [15,16]. Multiple nodules of the
lung are generally considered intrapulmonary metasta-
ses. There were multiple lesions in our first case, so we
had to determine whether the tumor was a primary or
secondary lesion. To this end, we performed an exten-
sive examination for the patient, including physical
examinations, gastrointestinal endoscopy, colonoscopy,
endoscopy of the nasalcavity, and positron emission
tomographic scanning of the brain. The results showed
no evidence of malignant melanoma elsewhere. In
addition, CT did not reveal a solitary lesion in the oc-
cipital lobe upon initial admission. Moreover, according
to the clinical and pathological criteria proposed by
Allen and Drash and others [1,8,17]– 1) no history sug-
gestive of a previous melanoma; 2) no demonstrable
melanoma in any other organ at the time of surgery;
3) a solitary tumor in the surgical specimen from the
lung; 4) tumor morphology compatible with that of aprimary tumor; 5) no evidence at autopsy of a primary
melanoma elsewhere; 6) obvious melanoma cells con-
firmed by immunohistochemical staining for S-100 and
HMB-45, and possibly by electron microscopy; 7) evi-
dence of junctional change; 8) “nesting” of cells beneath
the bronchial epithelium; 9) invasion of the intact bron-
chial epithelium by melanoma cells – we concluded that
the aforementioned data were indicative of primary lung
melanoma with intrapulmonary metastasis. Moreover,
we considered that the ninth view described in the above
diagnostic criteria was an important characteristic of pri-
mary pulmonary melanoma besides the evidence of
histopathological and immunohistochemical staining
according to the features of our both cases. The tumor
cells of primary pulmonary melanoma seemed also to in-
volve in the bronchial epithelium.
The optimal treatment for patients with primary ma-
lignant melanoma of the lung remains to be determined.
Some studies have demonstrated that the prognosis for
surgically-resected patients is better than that for non-
surgically treated patients [2]. Our second case confirms
this viewpoint. Of course, various chemotherapeutic
agents, including dacarbazine and immunotherapy with
interleukin-2 or interferon should be used as well. How-
ever, a cranial CT revealed a solitary lesion in the occipi-
tal lobe 3 months after the initial diagnosis for the first
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static malignant melanoma though a biopsy was not per-
formed. Therefore, we feel that an aggressive surgical
approach is warranted.
Conclusion
In conclusion, the extrapulmonary origin of malignant
melanoma must be excluded by detailed examination to
establish the diagnosis of primary pulmonary malignant
melanoma. The tumor should be removed surgically
whether it occurs as a single lesion or multiple lesions.
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